Samsung Biologics Co., the world’s largest contract drugmaker, will undergo a strategic split to separate its contract ...

WASHINGTON, D.C. – South Korean biosimilar giant Celltrion Inc. is accelerating its push to transform into a novel drug developer, going after a well-known pharmaceutical company in Europe to boost ...

The head of The Carlyle Group met with Korean retail investors in a rare session on Thursday, sharing insights on the US ...

South Korea’s largest institutional investor, the National Pension Service (NPS), remains a strong backer of the country’s ...

The head of Morgan Stanley’s Seoul office is stepping down after overseeing a series of landmark deals over more than a ...

Mirae Asset Global Investments Co. now manages more than 400 trillion won ($288 billion) in assets for the first time since ...

South Korea’s beauty industry has been reaping decent gains from traditionally strong markets such as China and the US – the ...

Samsung Electronics Co., the world’s top smart TV maker, plans to offer seven years of a free upgrade to its open-source smart TV operating system Tizen for its AI-powered TVs as the company strives ...

Google LLC is making a renewed push into the smart glasses market in partnership with South Korea’s Samsung Electronics Co.

South Korea’s leading biosimilar drug developer Celltrion Inc. on Sunday unveiled an anticancer medicine to expand new pipelines and accelerate its transformation into an original drug developer.

SK Earthon Co., the petroleum exploration and production (E&P) unit of South Korea’s top energy company SK Innovation Co., has secured rights to deve ...

EcoPro BM Co., a South Korean cathode materials producer, said on Tuesday it has signed a memorandum of understanding (MOU) with GEM, a Chinese battery materials and precursor supplier, to strengthen ...